← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #160 OF 1,000 MOST-CITED

Items to cover on annual reviews

FDA cited this observation 147 times across 141 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs147
BY FISCAL YEAR
FY20268
FY202516
FY202410
FY20239
FY20229
FY20215
FY202012
FY201926
FY201828
FY201724

How FDA worded it — real examples

Written procedures are not followed for evaluations done at least annually and including provisions for a review of complaints, recalls, returned or salvaged drug products and investigations conducted for each drug product.

Best Sanitizers Inc · Walton, Kentucky · Drugs · 2026-05-01

Written procedures are not established for evaluations done at least annually and including provisions for a review of complaints, recalls and returned or salvaged drug products.

MD Logistics, LLC · Plainfield, Indiana · Drugs · 2026-04-03

Written procedures are not established for evaluations done at least annually and including provisions for a review of complaints, recalls, returned or salvaged drug products and investigations conducted for each drug product.

Cosmetics & Cleaners International LLC · High Point, North Carolina · Drugs · 2026-03-26

Written procedures are not followed for evaluations done at least annually and including provisions for a review of investigations conducted for each drug product.

Omega & Delta Co., Inc. · Carolina, Puerto Rico · Drugs · 2026-03-20

Written procedures are not established and followed for evaluations done at least annually and including provisions for a review of complaints and investigations conducted for each drug product.

LPNA Group Inc. · Tonawanda, New York · Drugs · 2026-01-21

Written procedures are not followed for evaluations done at least annually and including provisions for a review of complaints, recalls, returned or salvaged drug products and investigations conducted for each drug product.

Custom Converting, Inc. · Oceanside, California · Drugs · 2026-01-16

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →